Address: Kevin O’Malley House, Earlsfort Centre, Earlsfort Terrace, Dublin 2,Ireland
Tel: 353-1-676 4971
Web: http://www.imb.ie/
The mission of the Irish Medicines Board (IMB) is
‘to protect and enhance public and animal health through the regulation of medicines, medical devices and healthcare products’
The objective of the IMB is to ensure in so far as possible, consistent with current medical and scientific knowledge, the quality, safety and efficacy of medicines available in Ireland and to participate in systems designed to do that throughout the European Union. Before a medicine can be authorised for use, an application must be made to the IMB and this must contain all of the necessary data supporting its quality, safety and efficacy.
The IMB is committed to the implementation and maintenance of a documented quality management system which is continually improved. The system is based on the requirements of the legislation, the regulatory system and ISO 9000:2000; it also takes into account guidelines, standards and best practices from Irish and international organisations.
Darren Cunningham tells us the story behind Inflection Biosciences (and its name), the rationale of focusing on small molecule cancer treatments, his thoughts on the Irish biotech start-up scene, and his hopes…
Richard Corbridge, first Chief Information Officer of the Health Service Executive (HSE) and CEO of the newly created eHealth Ireland, discusses Ireland’s ambitious plan to construct a new digital health…
Dr. Lorraine Nolan, Chief Executive of the Health Products Regulatory Authority (HPRA), the Irish regulatory agency, discusses the key objectives of the Strategic Plan 2016–2020, HPRA’s active participation in European…
Dermot O’Callaghan, cofounder and Director of Business Development, tells us the exciting story behind the genesis of Enterprise System Partners, an Irish success story providing manufacturing execution systems (MES) and…
Jack Daly, Commercial Manager at IMS Health Ireland, discusses the strategic decision of IMS Health to diversify into the health consultancy space, the importance of developing long-term partnerships with clients…
Colin Edwards, CEO of Merlin Consulting, a consulting firm providing services to the pharma, life sciences and digital health sectors in Ireland, discusses his reasons for leaving Boehringer Ingelheim to…
Dave Murphy, CEO of PM Group, the largest local service provider to the pharma industry in Ireland, highlights key developments of the group since 2013, their exciting internationalization and acquisition…
In an exclusive interview, Irish Minister for Foreign Affairs and Trade, Charles Flanagan TD, outlines the Department’s enhanced focus on trade and economic recovery, Ireland’s commitment to productive global engagement,…
Una Halligan, Chairperson of the Expert Group on Future Skills Needs (EGFSN), outlines the findings of its recently published report on the biopharma industry, the advantages Ireland can offer the…
Niall Barron, director of the NICB, discusses the Institute’s research, which has included significant research into Chinese Hamster Ovary (CHO) cell engineering and the identification of micro-RNA mechanisms that can…
Geraldine Freeman, Commercial Director at Johnson & Johnson Consumer Business in Ireland, discusses the increasing trend towards self-care in Ireland and the importance of the self-care agenda within the context…
Tony O’Brien, Director General of the Irish Health Service Executive (HSE), highlights the reforms instituted in the past few years, key challenges faced, his thoughts on the sustainability of the…
See our Cookie Privacy Policy Here
